Urticariahttps://en.wikipedia.org/wiki/Hives
Urticaria bụ ụdị ihe nfụkasị akpụkpọ ahụ nwere ọbara ọbara, gbalitere, na-afụ ụfụ. Ọtụtụ mgbe, ihe ọkụ ọkụ na-agagharị. Ha na-adịru ụbọchị ole na ole ma ha anaghị ahapụ mgbanwe akpụkpọ ahụ na-adịte aka. Ihe na-erughị 5% nke ikpe na-adị ihe karịrị izu isii. Urticaria na-emekarị mgbe ọrịa butere ọrịa ma ọ bụ n'ihi nfụkasị ahụ dị ka ọgwụ ma ọ bụ nri.

Mgbochi bụ site n'izere ihe ọ bụla na-akpata ọnọdụ ahụ. Ọgwụgwọ na-abụkarị ọgwụ antihistamines dị ka diphenhydramine na ranitidine. N'ọnọdụ ndị siri ike, a pụkwara iji corticosteroids ma ọ bụ ihe mgbochi leukotriene mee ihe. Idobe okpomọkụ gburugburu ebe obibi dị jụụ bara uru nwa oge. Maka ikpe ndị na-adịru ihe karịrị izu isii, enwere ike iji ọgwụ mgbochi immunosuppressants dị ka cyclosporin.

Ọ bụ ọrịa a na-ahụkarị n'ihi na ihe dịka 20% nke ndị mmadụ na-emetụta. Ọrịa urticaria dị ukwuu na-apụtakwa n'etiti nwoke na nwanyị ebe oge ogologo oge na-adịkarị na ụmụ nwanyị. Ọrịa urticaria dị ukwuu na-adịkarị n'etiti ụmụaka ebe ogologo oge na-adịkarị n'etiti ndị agadi. Ọ bụrụ na ọ dị ihe karịrị ọnwa 2, ọ na-adịru ọtụtụ afọ wee pụọ.

Ọgwụgwọ - Ọgwụ OTC
Nnukwu urticaria na-emekarị n'ime otu izu, mana urticaria na-adịghị ala ala nwere ike ịdịgide ruo ọtụtụ afọ n'agbanyeghị na ọtụtụ n'ime ha na-apụ n'oge ụfọdụ. N'ihe banyere urticaria na-adịghị ala ala, a na-atụ aro ka ị na-aṅụ ọgwụ antihistamine mgbe niile ma chere ka ọ pụọ n'onwe ya.

OTC antihitamine. Cetirizine ma ọ bụ levocetirizine dị irè karịa fexofenadine mana ọ na-eme ka ụra na-arahụ gị.
#Cetirizine [Zytec]
#LevoCetirizine [Xyzal]

Maka urticaria na-adịghị ala ala, a na-ahọrọ antihistamines na-adịghị ehi ụra dị ka fexofenadine.
#Fexofenadine [Allegra]
#Diphenhydramine [Benadryl]
#Loratadine [Claritin]
☆ Na nsonaazụ Stiftung Warentest nke 2022 sitere na Germany, afọ ojuju ndị ahịa na ModelDerm dị ntakịrị ntakịrị karịa na nyocha telemedicine akwụ ụgwọ.
  • Ọnya a na-enyo enyo na ọ bụ Erythema multiforme minor ma ọ bụ urticarial vasculitis kama ịbụ urticaria na-ahụkarị.
  • Ọ bụ ihe a na-ahụkarị nke hives. Ọnya nwere ike ịkwaga kwa awa ole na ole.
  • Urticaria - ogwe aka
  • Cold urticaria
  • Cold urticaria
  • Hives na mgbidi igbe aka ekpe. Rịba ama na ọnya ahụ dị ntakịrị elu.
  • A na-ahụkarị urticaria
  • Urticarial Vasculitis
  • Dermographic urticaria; Ọ na-abụkarị urticaria na-adịghị ala ala ma nwee ike ịdịgide ruo ọtụtụ afọ tupu ọ pụọ na mberede.
  • Dermatographic urticaria
References Acute and Chronic Urticaria: Evaluation and Treatment 28671445
A na-ejikwa urticaria, nke na-enwekarị itching whal na mgbe ụfọdụ ọzịza nke elu akpụkpọ ahụ dị omimi, na-achịkwa ya site n'izere ihe ndị na-akpali akpali, ma ọ bụrụ na amara ya. Ọgwụgwọ bụ isi gụnyere ọgwụ mgbochi H1 nke ọgbọ nke abụọ, nke enwere ike ịhazi ya na oke doses ma ọ bụrụ na achọrọ ya. Ọzọkwa, ọgwụ ndị ọzọ dị ka ọgbọ mbụ H1 antihistamines, H2 antihistamines, leukotriene receptor antagonists, ike antihistamines, na obere ọmụmụ nke corticosteroids nwere ike iji n'akụkụ. Maka ikpe na-adịgide adịgide, a ga-atụle ntụnye aka na ndị ọkachamara maka ọgwụgwọ ọzọ dị ka omalizumab ma ọ bụ cyclosporine.
Urticaria, often characterized by itchy wheals and sometimes swelling of the deeper skin layers, is typically managed by avoiding triggers, if known. The primary treatment involves second-generation H1 antihistamines, which can be adjusted to higher doses if needed. Additionally, other medications like first-generation H1 antihistamines, H2 antihistamines, leukotriene receptor antagonists, potent antihistamines, and short courses of corticosteroids may be used alongside. For persistent cases, referral to specialists for alternative therapies like omalizumab or cyclosporine may be considered.
 Urticaria and Angioedema: an Update on Classification and Pathogenesis 28748365
 Chronic Urticaria 32310370 
NIH
Second-generation H1-antihistamines (e.g., cetirizine, loratadine, fexofenadine), Omalizumab, Ciclosporin, and short courses only of systemic corticosteroids
 Angioedema 30860724 
NIH
Angioedema bụ ọzịza nke na-adịghị ahapụ olulu mgbe a pịara ya, na-eme n'ígwé dị n'okpuru akpụkpọ ahụ ma ọ bụ akpụkpọ anụ mucous. Ọ na-emetụtakarị ebe dị ka ihu, egbugbere ọnụ, olu, na aka, yana ọnụ, akpịrị, na eriri afọ. Ọ na-adị ize ndụ mgbe ọ na-emetụta akpịrị, nwere ike ịkpata ọnọdụ egwu ndụ.
Angioedema is non-pitting edema that involves subcutaneous and/or submucosal layers of tissue that affects the face, lips, neck, and extremities, oral cavity, larynx, and/or gut. It becomes life-threatening when it involves the larynx.